Expertise: Clinical program development/strategy and protocol design in a variety of therapeutic areas, especially critical care and cardiovascular, for both drugs and biologics. Strategic regulatory guidance regarding clinical development issues

Dr. Freitag has worked in the pharmaceutical industry for more than 30 years in positions including Vice President, New Drug Development at The Liposome Company and, most recently, as Vice President of Research & Development at Bone Care International. He previously worked at PharmaNet as Senior Vice President of Medical and Scientific Affairs prior to joining Bone Care. Dr. Freitag is board certified in both Internal Medicine and Nephrology and has a strong academic, scientific, and clinical background. He has extensive experience in providing medical and scientific direction and leadership to product development teams. He has also provided strategic clinical-development consultation to clients in a variety of therapeutic areas, particularly multiple critical care (renal, pulmonary, cardiovascular and infectious disease) therapeutic areas.